François Moreau‐Gaudry

3.6k total citations · 1 hit paper
79 papers, 2.7k citations indexed

About

François Moreau‐Gaudry is a scholar working on Molecular Biology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, François Moreau‐Gaudry has authored 79 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 17 papers in Genetics and 15 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in François Moreau‐Gaudry's work include Porphyrin Metabolism and Disorders (30 papers), CRISPR and Genetic Engineering (20 papers) and Virus-based gene therapy research (17 papers). François Moreau‐Gaudry is often cited by papers focused on Porphyrin Metabolism and Disorders (30 papers), CRISPR and Genetic Engineering (20 papers) and Virus-based gene therapy research (17 papers). François Moreau‐Gaudry collaborates with scholars based in France, United States and Belize. François Moreau‐Gaudry's co-authors include Hubert de Verneuil, Cécile Ged, Sandrine Dabernat, Aurélie Bedel, Josy Reiffers, Françis Belloc, François‐Xavier Mahon, Valérie Lagarde, John M. Goldman and Claudine Chollet and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

François Moreau‐Gaudry

79 papers receiving 2.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations

2019 310 citations Grégoire Cullot, Julian Boutin et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
François Moreau‐Gaudry France	28	1.8k	475	460	453	392	79	2.7k
Edward F. Fritsch United States	18	2.1k 1.1×	985 2.1×	948 2.1×	532 1.2×	882 2.3×	25	4.1k
Angus M. Sinclair United States	25	1.6k 0.9×	917 1.9×	577 1.3×	733 1.6×	237 0.6×	60	2.9k
Scott P. Henry United States	35	2.7k 1.5×	261 0.5×	242 0.5×	312 0.7×	423 1.1×	105	3.8k
Seth J. Corey United States	35	1.4k 0.8×	996 2.1×	850 1.8×	465 1.0×	484 1.2×	114	3.5k
Martin A. Horstmann Germany	31	2.2k 1.2×	1.6k 3.4×	914 2.0×	191 0.4×	254 0.6×	90	4.9k
Wendy Schober United States	34	1.8k 1.0×	751 1.6×	729 1.6×	107 0.2×	381 1.0×	64	3.0k
Takaomi Sanda Singapore	35	3.1k 1.7×	916 1.9×	1.0k 2.3×	203 0.4×	296 0.8×	108	4.5k
A Bank United States	29	2.1k 1.2×	844 1.8×	626 1.4×	1.2k 2.6×	1.1k 2.8×	75	3.9k
Hiroshi Okuda Japan	24	1.7k 1.0×	400 0.8×	794 1.7×	204 0.5×	167 0.4×	80	2.9k
Ulrich Maurer Germany	26	2.4k 1.3×	488 1.0×	813 1.8×	146 0.3×	191 0.5×	43	3.4k

Countries citing papers authored by François Moreau‐Gaudry

Since Specialization

Citations

This map shows the geographic impact of François Moreau‐Gaudry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Moreau‐Gaudry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Moreau‐Gaudry more than expected).

Fields of papers citing papers by François Moreau‐Gaudry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Moreau‐Gaudry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Moreau‐Gaudry. The network helps show where François Moreau‐Gaudry may publish in the future.

Co-authorship network of co-authors of François Moreau‐Gaudry

This figure shows the co-authorship network connecting the top 25 collaborators of François Moreau‐Gaudry. A scholar is included among the top collaborators of François Moreau‐Gaudry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Moreau‐Gaudry. François Moreau‐Gaudry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Amintas, Samuel, Charles Dupin, Marie‐Alix Derieppe, et al.. (2025). Resveratrol and capsaicin as safer radiosensitizers for colorectal cancer compared to 5-fluorouracil. Biomedicine & Pharmacotherapy. 183. 117799–117799. 2 indexed citations

Cullot, Grégoire, Julian Boutin, David Cappellen, et al.. (2023). Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9. Nature Communications. 14(1). 4072–4072. 16 indexed citations

Cullot, Grégoire, Samuel Amintas, Valérie Prouzet‐Mauleon, et al.. (2023). Specific High-Sensitivity Enzymatic Reporter UnLOCKing-Mediated Detection of Oncogenic BCR::ABL1 and EGFR Rearrangements. The CRISPR Journal. 6(2). 140–151. 3 indexed citations

Boutin, Julian, David Cappellen, Samuel Amintas, et al.. (2022). ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected. The CRISPR Journal. 5(1). 19–30. 29 indexed citations

Toutain, Jérôme, Julian Boutin, Samuel Amintas, et al.. (2020). Mutation-Specific Guide RNA for Compound Heterozygous Porphyria On-target Scarless Correction by CRISPR/Cas9 in Stem Cells. Stem Cell Reports. 15(3). 677–693. 4 indexed citations

Buscail, Étienne, L. Chiche, Camille Laurent, et al.. (2019). Tumor‐proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells. Molecular Oncology. 13(9). 1811–1826. 31 indexed citations

Vendrely, V., Evelyne Peuchant, Étienne Buscail, et al.. (2017). Resveratrol and capsaicin used together as food complements reduce tumor growth and rescue full efficiency of low dose gemcitabine in a pancreatic cancer model. Cancer Letters. 390. 91–102. 56 indexed citations

Ducassou, Stéphane, Valérie Prouzet‐Mauleon, Marie‐Céline Deau, et al.. (2017). MYB–GATA1 fusion promotes basophilic leukaemia: involvement of interleukin‐33 and nerve growth factor receptors. The Journal of Pathology. 242(3). 347–357. 10 indexed citations

Mahon, F-X, Isabelle Lamrissi‐Garcia, Isabelle Moranvillier, et al.. (2016). Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells. Leukemia. 31(1). 65–74. 11 indexed citations

10.

Lafitte, M., Benoı̂t Rousseau, Isabelle Moranvillier, et al.. (2012). In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens. Molecular Cancer. 11(1). 81–81. 16 indexed citations

11.

Richard, Élodie, Magalie Lalanne, Isabelle Lamrissi‐Garcia, et al.. (2010). Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation. The Journal of Gene Medicine. 12(8). 637–646. 6 indexed citations

12.

Richard, Élodie, François Moreau‐Gaudry, Magalie Lalanne, et al.. (2008). Effective Gene Therapy of Mice with Congenital Erythropoietic Porphyria Is Facilitated by a Survival Advantage of Corrected Erythroid Cells. The American Journal of Human Genetics. 82(1). 113–124. 37 indexed citations

13.

Richard, Emmanuel, Élodie Richard, Cécile Ged, François Moreau‐Gaudry, & Hubert de Verneuil. (2008). Erythropoietic Porphyrias: Animal Models and Update in Gene-Based Therapies. Current Gene Therapy. 8(3). 176–186. 21 indexed citations

14.

Rousseau, Benoı̂t, Ludovic Ménard, Valérie Haurie, et al.. (2007). Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology. 46(4). 1108–1118. 90 indexed citations

15.

Richard, Emmanuel, Isabelle Redonnet‐Vernhet, Isabelle Lamrissi‐Garcia, et al.. (2003). Highly Efficient Lentiviral Gene Transfer in CD34 ⁺ and CD34 ⁺ /38 ⁻ /lin ⁻ Cells from Mobilized Peripheral Blood after Cytokine Prestimulation. Stem Cells. 21(4). 472–480. 20 indexed citations

16.

Fontanellas, Antonio, Manuel Méndez, Frédéric Mazurier, et al.. (2001). Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells. Gene Therapy. 8(8). 618–626. 22 indexed citations

17.

Mazurier, Frédéric, Antonio Fontanellas, Stéphanie Salesse, et al.. (1999). A Novel Immunodeficient Mouse Model-RAG2 gamma Cytokine Receptor Chain Double Mutants-Requiring Exogenous Cytokine Administration for Human Hematopoietic Stem Cell Engraftment Common. Journal of Interferon & Cytokine Research. 19(5). 533–541. 94 indexed citations

18.

Mazurier, Frédéric, François Moreau‐Gaudry, Véronique Maguer‐Satta, et al.. (1998). Rapid analysis and efficient selection of human transduced primitive hematopoietic cells using the humanized S65T green fluorescent protein. Gene Therapy. 5(4). 556–562. 15 indexed citations

19.

Ged, Cécile, et al.. (1995). Identification of Two NewMutations in CongenitalErythropoietic Porphyria. European Journal of Human Genetics. 3(2). 102–107. 19 indexed citations

20.

Verneuil, Hubert de, et al.. (1995). Porphyrias: Animal models and prospects for cellular and gene therapy. Journal of Bioenergetics and Biomembranes. 27(2). 239–248. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact